JRS Pharma joins forces with Celonic

Published: 9-Sep-2015 Featured companies: JRS Pharma
Manufacturing Ingredients Finance Pharmaceutical

Deal will enable JRS to provide biopharma services to health science


JRS Pharma, producer of world-leading cellulose products for the health science industry, has added Celonic to its portfolio of products and services.

Celonic is a contract development and manufacturing organisation (CDMO) offering comprehensive development and manufacturing services for biotherapeutics. These services include the development of high yield production cell lines, efficient up-stream and down-stream processes, full GMP analytics, and the manufacture of active pharmaceutical ingredients (APIs) in cell culture systems at different scales of up to 1000 litres.

In addition, Celonic licenses its proprietary SEFEX (Serum Free Expression) cell line technology to clients, drug developers and other service providers.

Celonic offers a wide range of biopharma services and expertise for new biological entities, biosimilars and cell lines.

Featured companies

JRS Pharma is a leading manufacturer of excipients, offering a complete portfolio of excipient solutions for the pharmaceutical and nutraceutical industries. Our excipients...
  • Companies:
  • Celonic GmbH
See more

You may also like

Manufacturing

JRS Pharma builds new manufacturing facility in Iowa, USA

Read more
It will add a number of new high-value jobs with positions in operations, maintenance, warehouse, and quality

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
  2. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  3. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
  4. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance

Relevant companies

See more

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

JRS Pharma builds new manufacturing facility in Iowa, USA

It will add a number of new high-value jobs with positions in operations, maintenance, warehouse, and quality
Ingredients

Introducing LUBRITAB RBW (Rice Bran Wax)

The clean label lubricant for tablet and capsule formulations
Manufacturing

Optimise continuous manufacturing using PROSOLV EASYtab

Learn more about PROSOLV EASYtab from JRS Pharma
Manufacturing

Ti02-free coating platform for EU tablet producers

Vivacoat free has been launched to help manufacturers formulate products without titanium dioxide
Research & Development

Celonic Group and UCL announce partnership

The agreement gives UCL access to Celonic’s CHOvolution platform
Manufacturing

Celonic to boost ATMP production at upcoming Swiss life science park

The CDMO has planned a two-phase expansion of a facility, adding up to 20 GMP cleanroom suites and offices along with laboratories for process development, method development and quality control services
Manufacturing

Comprehensive analysis into disintegration mechanisms: How reliable are textbook recommendations?

New white paper by Emily Sabath Scientist, Research & Development at JRS Pharma
Subscribe now